Loading chart data...
DexCom is rallying in pre-market action following the company's Investor Day presentation held yesterday afternoon. The move is driven by the announcement that the company has reached an agreement with activist investor Elliott Investment Management to appoint two new independent directors and revamp key board committees. This governance overhaul, coupled with the strategic updates shared during the Investor Day event, appears to be fueling positive sentiment among traders as they digest the company's forward-looking plans.
No significant catalyst events detected.